диссертации / 99

284.Honda I. Uterine artery embolization for leiomyoma: complications and effects on fertility / I.Honda, T.Sato, H.Adachi [et al.] // Nihon Igaku Hoshasen Gakkai Zasshi. – 2003. − Jul. – V.63 (6). – P.294-302.

285.Hovsepian D.M. A prospective comparison of the impact of uterine artery embolization, myomectomy, and hysterectomy on ovarian function / D.M.Hovsepian, V.SRatts, M.Rodrigues [et al.] // J.Vasc. Interv. Radiol. – 2006. – V.17. – №7. − P.1111-1115.

286.Hrqovic Z. New options in the diagnosis and management of uterine myoma / Z.Hrqovic, T.Kulas, D.Habek [et al.] // Med Arh. − 2008. – V.62 (4). – P.234-239.

287.Hu K. Expression of estrogen receptors ERalpha and ERbeta in endometrial hyperplasia and adenocarcinoma /K.Hu, G.Zhong, F.He // Int. J. Gynecol. Cancer. – 2005. – V.15. – N.3. – P.537-541.

288.Huerta S. Screening and Detection of Apoptosis / S.Huerta, E.J.Goulet, S.Huerta-Yepez // J. of Surgical Research. − 2007. −V.139. − Issue 1. − P.143-156.

289.Hutchins Jr. F.L. Patient selection, indication and contraindications // In: Uterine fibroids. Embolization and other treatmens / Jr. F.L.Hutchins // Edited by Togas Tulandi-Cambrige Press. − 2003. − P.97-100.

290.Imaoka I. MR imaging of disorders associated with female infertility: Use in diagnosis, treatment, and management / I.Imaoka, A.Wada, M.Matsuo [et al.] // Radiographics. − 2003. −23. −P.1401-1421.

291.Ishihara H. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expressione in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyosis / H.Ishihara, J.Kitawaki, N.Kado [et al.] // Fertil. Steril. − 2003. − V.79 (Suppl. 1). − P.735-742.

292.Isonishi S. Analysis of prognostic factors for patients with leiomyoma treated with uterine arterial embolization / S.Isonishi, R.L.Coleman,

261

M.Hirama [et al.] // Am J. Obstet Gynecol. – 2008. – V.198. – N.3. –

P.270.e1-6.

293.Izadi-Mood N. Determining the interand intraobserver reproducibility of the diagnosis of endometrial hyperplasia subgroups and welldifferentiated endometrioid carcinoma in endometrial curettage specimens / N.Izadi-Mood, M.Khaniki, G.Irvanloo [et al.] // Arch. Iran Med. – 2009. – V.12. – N.4. – P.377-382.

294.Jones K. A case of failed fibroid embolisation due to an unusual vascular supply /K. Jones, W.J. Walker, C. Sutton // BJOG. – 2003. Aug. –V.110

(8). – P.782-3.

295.Jun F. Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta-analysis of the literature / F.Jun, L.Yamin, X.Xinli [et al.] // Arch Gynecol Obstet. – 2012. − 285(5). − P.1407-1413.

296.Kapucuoglu N. Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index / N.Kapucuoglu, F.Aktepe, H.Kaya [et al.] // Pathol. Res. Pract. – 2007. – V.203. – №.3. –

P.153-162.

297.Katsumori T. Amenorrhea and resumption of menstruation after uterine artery embolization for fibroids /T.Katsumori, T.Kasahara, Y.Tsuchida [et al.] // Int J. Gynaecol. Obstet. – 2008. – V.103. – N.3. – P.217-221.

298.Kayisli U.A. Expression of proliferative and preapoptotic molecules in human myometrium and leiomyoma throughout the menstrual cycle / U.A.Kayisli, M.Berkkanoglu, G.Kizilay [et al.] // Reprod. Sci. – 2007. – V.14. – №7. – P.678-686.

299.Khaund A. Evaluation of the effect uterine artery embolization on menstrual blood loss and uterine volume / A.Khaund, J.G.Moss, N.McMillan [et al.] // BJOG. – 2004. – V. 111. – N.7. – P.700-705.

262

300.Kheda Amitha Vikrama S. The role of uterine artery embolization in gynecology practice / S.Kheda Amitha Vikrama, C.Ramamurthy // Apollo Medicine. − 2012. − V.9. − Issue 3. −P.206-211.

301.Kim H.S. Effects of utero-ovarian anastomoses on clinical outcomes and repeat intervention rates after uterine artery embolization / H.S.Kim, J.Tsai, A.Patra [et al.] // J. Vasc Interv Radiol. − 2006. − May. – V.17(5).

– P.783-789.

302.Kim H.S. Long-term efficacy and safety of uterine artery embolization in young patients with and without uteroovarian anastomoses / H.S.Kim, B.E.Paxton, J.M.Lee // J. Vasc Interv Radiol. – 2008. – V.19 (2 Pt 1). – P.195-200.

303.Kim M.D. Long-term results of symptomatic fibroids treated with uterine artery embolization: in conjunction with MR evaluation / M.D.Kim, H.S.Lee, M.H.Lee [et al.] // Eur J. Radiol. – 2010. – V.73. – №.2. –

P.339-344.

304.Kim M.D. Long-term results of uterine artery embolization for symptomatic adenomyosis / M.D.Kim, S.Kim, N.K.Kim [et al.] // AJR Am J. Roentgenol. − 2007. − 188. – Р.176-181.

305.Kim M.D. Pregnancy following uterine artery embolization with polyvinyl alcohol particles for patients with uterine fibroid or adenomyosis / M.D.Kim, N.K.Kim, H.J.Kim [et al.] // Cardiovasc. Intervent. Radiol. – 2005. – V.28. – №5. – P.611-615.

306.Kim T.J. Clinical outcomes of patients treated for cervical pregnancy with or without methotrexate / T.J.Kim, S.J.Seong, K.J.Lee [et al.] // J. Korean Med Sci. − 2004. −19. − P.848–852.

307.Kitamura Y. MRI of adenomyosis: changes with uterine artery embolization / Y.Kitamura, S.J.Allison, R.C.Jha [et al.] // AJR Am J. Roentgenol. − 2006. − 186. − P.855-864.

263

308.Kjerulff K.H. Patient satisfaction with results of hysterectomy / K.H.Kjerulff, J.C.Rhodes, P.W.Langenberg [et al.] // American J. of Obstetrics & Gynecology. − 2000. – V.183. − Issue 6. – P.1440-1447.

309.Kobayashi T.K. Cellular changes following uterine artery embolization for the treatment of adenomyosis / T.K.Kobayashi, M.Ueda, T.Nishino et al. // Cytopathology. – 2001. − 12(4) – Р.270–272.

310.Koh J. Uterine artery embolization (UAE) for diffuse leiomyomatosis of the uterus: clinical and imaging results / Koh J., Kim M.D., Jung D.C., Lee M., Lee M.S., Won J.Y., Lee do Y., Park S.I., Lee K.H. / Eur J. Radiol. – 2012. – 81 (10) – Р.726-729.

311.Kostál M. Pregnancy after uterine artery embolization in uterine myoma

/ M.Kostál, J.Tosner, J.Náteková, L.Rousková // Ceska Gynekol. – 2004. Jan. – 69 (1). – Р.48-50.

312.Kröncke T.J. Uterine fibroid embolization: a new therapeutic option for symptomatic leiomyomata of the uterus [in German] / T.J.Kröncke, A.Gauruder-Burmester, B.Hamm // Rofo. − 2002. −V.174. −P.12271235.

313.Kung F.T. Differential diagnosis of suspected cervical pregnancy and conservative treatment with the combination of laparoscopy-assisted uterine artery ligation and hysteroscopic endocervical resection / F.T.Kung, H.Lin, T.Y.Hsu [et al.] // Fertility and Sterility. − 2004. − 81.

−P.1642–1649.

314.Kuppermann M. Effect of hysterectomy vs medical treatment on healthrelated quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial / M.Kuppermann, R.E.Varner, R.L.Jr. Summitt [et al.] // JAMA. – 2004. – V.291. – P.1447-1455.

315.Lai A.C. Sexual Dysfunction after Uterine Artery Embolization / A.C.Lai, S.C.Goodwin, S.M.Bonilla [et al.] // JVIR. – 2000. − 11. − P.755-7.

264

316.Lalinec-Michaud M. Anxiety, fears and depression related to hysterectomy / M.Lalinec-Michaud, F. Engelsmann // Can J Psychiatry. − 1985. – V.30. – P.44-47.

317.Lal-Nag M. The claudins / M.Lal-Nag, P.J.Morin // Genome Biol. – 2009. – V.10. – N.8. – P.235.

318.Lanciego C. Utero-ovarian Anastomoses and Their Influence on Uterine Fibroid Embolization / C.Lanciego, I.Diaz-Plaza, J.J.Ciampi [et al.] // J. Vasc Interv Radiol. – 2012. – Mar. – V.20.

319.Lee D.W. The direct and indirect cost burden of clinically significantand symptomatic uterine fibroids / 397.Lee D.W., Ozminkowski R.J., Carls G.S. [et al.] // J. Occup Environ Med. – 2007. – V.49. – P.493-506.

320.Lefebvre G. Society of Obstetricians and Gynaecologists of Canada, Canadian Association of Radiologists, Canadian Interventional

Radiology Association. Uterine fibroid emboliation (UFE) / G.Lefebvre, G. ilos, M.Asch // J. Obstet Gynaecol Can. – 2004. – V.26 (899-911). – P.913-928.

321.Lihara K. Leiomyosarcoma with dedifferentiation in a premenopausal patient discovered after uterine artery embolization / K.Lihara, K.Hirano, Y.Fujioka [et al.] // Pathol Int. – 2007. – V.57. – №10. – P.681-687.

322.Linda D. Uterine fibroid embolization: a viable alternative to hysterectomy / Linda D. Bradley M.D. / From the Department Obstetrics and Gynecology, Cleveland Clinic, Cleveland, OH. Received July 24 – 2008. − revised Dec. – 18 – 2008. − accepted Jan. – 16 − 2009.

323.Liu P., Chen C., Liu L., Liu J. Investigation of the hemodynamic changes during uterine arterial embolization in the treatment of adenomyosis / P.Liu, C.Chen, L.Liu, J.Liu // Zhonghua Fu Chan Ke Za Zhi – 2002. − 37(9). – Р.536–538.

265

324.Lohle P.N. Long-term outcome of uterine artery embolization for symptomatic uterine leiomyomas / P.N.Lohle, M.J.Voogt, J. De Vries [et al.] // J. Vasc. Interv Radiol. – 2008. – V.19. – №3. – P.319-326.

325.Lohle P.N. Uterine artery embolization for symptomatic adenomyosis with or without uterine leiomyomas with the use of calibrated tris-acryl gelatin microspheres: midterm clinical and MR imaging follow-up / P.N.Lohle, J.De Vries, C.A.Klazen [et al.] // J. Vasc Interv Radiol. – 2007. – 18. – P.835–841.

326.Lopes R.G.C.Analysis of estrogenand progesterone-receptor expression in endometrial polyps / Lopes R.G.C., Baracat E.C., L.de Albuquerque Neto C //The Journal of Minimally Invasive Gynecology. – 2007. –V.14, Issue 3, P.300-303.

327.Lowenstein L. Does hysterectomy affect genital sensation? / L.Lowenstein, D.Yarnitsky, I.Gruenwald [et al.] // Eur J. Obstet Gynecol Reprod Biol. – 2005. – 4. –P.119.

328.Luo X. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGFbeta in leiomyoma and myometrial smooth muscle cells / X.Luo, L.Ding, N.Chegini // Mol Hum Reprod. – 2006. – Apr. – V.12 (4). – Р.245-256.

329.Luo X. Leiomyoma and myometrial gene expression profiles and T response to gonadotropin releasing hormone analogue (GnRHa) therapy / X.Luo, L.Ding, J.Xu [et al.] // Endocrinology. – 2004. – V.16.

330.Lupattelli T. Percutaneous uterine artery embolization for the treatment of symptomatic fibroids: current status /T.Lupattelli, A.Basile, F.G.Garaci [et al.] // Eur J. Radiol. – 2005. – Apr. – V.54 (1). – P.136-47.

331.Lyman G.H.Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology Clinical Practice guideline update / G.H.Lyman, A.A.Khorana, N.M.Kuderer [et al.] // J. Clin Oncol. – 2013. – V.31. – P.2189–2204.

266

332.Lyon S.M. Uterine artery embolisation – a treatment alternative for women with fibroids /S.M. Lyon, K. Cavanagh // Aust Fam. Physician. – 2006. May. – V.35 (5). – P.300-303.

333.Ma X.X. Expression of aromatase protein and sex hormone receptor in endometrial lesions /X.X.Ma, S.L.Zhang, S.Gao [et al.] // Zhonghua Fu Chan Ke Za Zhi. – 2006. – V.41. – N.6. – P.395-398.

334.Maas C.P. Objective assessment of sexual arousal in women with a history of hysterectomy./C.P.Maas, M.M. ter Kuile, Laan E. [et al.] // BJOG. – 2004. – 173(3). – P.929.

335.Maheux-Lacroix S. Uterine artery embolization complicated by uterine perforation at the site of previous myomectomy /S. Maheux-Lacroix, M. Lemyre, P.Y. Laberge [et al.] // J. Minim Invasive Gynecol. – 2012. Jan.

– V.19 (1). – P.128-130.

336.Malartic C. Role of mifepristone for the treatment of uterine fibroid / C.Malartic, O.Morel, G.Akerman [et al.] // Gynecol. Obstet. Fertil. – 2008. – V.36. – N.6. – P.668-674.

337.Malhotra A.D. Persistent Sciatic Artery and Successful Uterine Artery Embolization: Report of Three Cases /A.D.Malhotra, H.S.Kim// J. Vasc Intery Radiol. – 2009. Apr. – P.21.

338.Malik S. Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-alpha in menstrual endometrium and effluent in women with menorrhagia./ S.Malik, K.Day, I.Perrault [et al.] // Hum Reprod. – 2006. – V.21. - P.2158-2166.

339.Malzoni M. Optimizing the total laparoscopic hysterectomy procedure for benign uterine pathology /M. Malzoni, G. Perniola, F. Perniola [et al.]// J Am Assoc Gynecol Laparosc. – 2004. – May. – V.11 (2). – P.211218.

340.Mara M. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy

267

/ M.Mara, J.Maskova, Z.Fucikova [et al.] // Cardiovasc. Intervent. Radiol.

– 2008. – V.31. – N.1. – P.73-85.

341.Mara M. Hysteroscopy after uterine fibroid embolization in women of fertile age / M.Mara, Z.Fucikova, D.Kusel [et al.] // J. Obstet Gynaecol Res. – 2007. – V.33. – N.3. – P.316-324.

342.Mara M. Hysteroscopy after uterine fibroid embolization: Evaluation of intrauterine findings in 127 patients /M.Mara, P.Horak, K.Kubinova [et al.] // J. Obstet Gynaecol Res. – 2012. – Mar13.

343.Mara M. Uterine artery embolization versus laparoscopic uterine artery occlusion: the outcomes of a prospective, nonrandomized clinical trial / M.Mara, K.Kubinova, J.Maskova [et al.] // Cardiovasc Intervent Radio. – 2012. –35. – Р.1041–1052.

344.Mark D. Levie Uterine Artery Embolization: Laparoscopic myomectomy. XVI world congress of the International Federation of Gynecology and Obstetrics. – 2000.

345.Martin Chaves E.B. Insulin-like growth factor 1 receptor mRNA expression and autophosphorylation in human myometrium and leiomyoma /E.B. Martin Chaves, I.S. Brum, J. Stoll [et al.] // Gynecol. Obstet. Invest. – 2004. – V.57. – №.4. – P.210-213.

346.Marx M. Ovarian protection by occlusion of uteroovarian collateral vessels before uterine fibroid embolization / M.Marx, J.P.Wack, E.L.Baker [et al.] // J. Vasc. Interv. Radiol. – 2003. – V. 14. – P.13291332.

347.Massart F. Analysis of estrogen receptor and progesterone receptor

polymorphisms in uterine leiomyomas /F. Massart, L. Becherini, F.

Marini [et al.] // Med Sci Monit. – 2003. – V.9 (1). – BR.25-30.

348. Matteo M. Combined medical-hysteroscopic conservative treatment of a viable cervical pregnancy: a case report /M.Matteo, L.Nappi,

268

P.Rosenberg [et al.] // J. of Minimally Invasive Gynecology. – 2006. –

V.13. –P.345–347.

349.Mattews J. Estrogen signaling: a subtle balance between ER alpha and beta /J.Mattews, J.A. Gustafsson // Mol. Interv. – 2003. – V.3. – N.5. – P.281-292.

350.McCampbell A.S. Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium/A.S.McCampbell, R.R.Broaddus, D.S.Loose [et al.] // Clin. Cancer. Res. – 2006. – V.12. – №.21. – P.6373-6378.

351.McEwan I.J. Nuclear receptors: one big family/ I.J. McEwan // Methods Mol Biol. – 2009. – V.505. – P.3-18.

352.McLucas B. Adenomyosis: MRI of the uterus treated with uterine artery

2004. – V.182 (4). – P.1084–1085; author reply 1085.

353.McLucas B. Computed tomography angiogram for failed uterine artery embolization/ B.McLucas, B. aghmail, M.Beller //Minim Invasive Ther Allied Technol. –2009. – V.1. – P.1-6.

354.McLucas B. Pregnancy following uterine artery embolization: An update / B. McLucas //Minim Invasive Ther Allied Technol. – 2012. Oct 4.

355.McLucas B. Repeat uterine artery embolization following poor results /B. McLucas, R.A. Reed //Minim Invasive Ther Allied Technol. – 2009.

– V.1. – P.1-5.

356.McLucas B. Uterine fibroid embolization: nonsurgical treatment for symptomatic fibroids / B. McLucas, L. Adler, R. Perrella//J.Am.Coll. Surg. -2001. -Vol. 192(1). -P.95-105.

357.Meston С. The Effects of Hysterectomy on the Subjective and Physiological Sexual Function of Women with Benign Uterine Fibroids /C. Meston//.Archives of Sexual Behavior. – 2004. – V. 33. – N.1. – P.31-42.

269

358.Mettler L. Treatment of myomas by laparoscopic and laparotomic myomectomy and laparoscopic hysterectomy/L. Mettler, T. Schollmeyer, L. Lehmann-Willenbrock [et al.] // Minim Invasive Ther. Allied Technol.

– 2004. Feb. 13(1). – P.58-64.

359.Miller C.E. Unment therapeutic needs for uterine myomas /C.E. Miller// J Minim Invasive Gynecol. – 2009. - Jan-Feb. – Vol.16 (1). – P.11-21.

360.Mints M. Expression of aquaporin-1 in endometrial blood vessels in menorrhagia / M.Mints, A.Hildenbrand, L.P.Lalitkumar [et al.] // Int.J. Mol. Med. – 2007. –19. – P.407-411.

361.Mints M. Expression of vascular endothelial growth factor receptor-3 in the endometrium in menorrhagia./ M.Mints, B.Blomgren, J.Palmblad // Int. J. Mol. Med. – 2007. –19. –P.909–913.

362.Mints M. Microvascular density, vascular endothelial growth factor A, and its receptors in endometrial blood vessels in patients with menorrhagia / M.Mints, B.Blomgren, C.Falconer [et al.] // Fertil Steril. – 2005. – 84. – P.692-700.

363.Mohan P.P. Uterine Artery Embolization and Its Effect on Fertility / P.P.Mohan, M.H.Hamblin, R.L.Оgelzang // J. of Vascular and Interventional Radiology. – 2013. – V. 24.– Issue 7.– P.925-930.

364.Mooller B. Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system./ B.Mooller, M. Roonnerdag, G.Wang [et al. ] // Hum Reprod. – 2005. – 20. – P.1410-1417.

365.Moore E. Endometrial hyperplasia / E.Moore, M.Shafi // Obstetrics, Gynaecology and Reproductive Medicine. –2013. – V. – 23. – Issue 3.– P.88-93.

366.Morales Godoy H.S.G.H. Claudin 5 as a marker of endometrial

receptivity in patients with previous implantation failure /

270